Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features

Published:2016-11 Issue:11 Volume:22 Page:1988-1996
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Rasche Leo,Röllig Christoph,Stuhler Gernot,Danhof Sophia,Mielke Stephan,Grigoleit Goetz Ulrich,Dissen Lea,Schemmel Lea,Middeke Jan Moritz,Rücker Viktoria,Schreder Martin,Schetelig Johannes,Bornhäuser Martin,Einsele Hermann,Thiede Christian,Knop Stefan

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference54 articles.

1. Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma;Garban;Blood,2006

2. A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma;Rosinol;Blood,2008

3. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up;Bjorkstrand;J Clin Oncol,2011

4. Autologous followed by allogeneic versus tandem-autologous stem cell transplant in newly diagnosed FISH-del13q myeloma;Knop;Blood,2014

5. A comparison of allografting with autografting for newly diagnosed myeloma;Bruno;N Engl J Med,2007

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods;Human Immunology;2024-05

2. Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation;The Journal of Molecular Diagnostics;2024-04

3. Chimerism After Hematopoietic Stem Cell Transplantation;Comprehensive Hematology and Stem Cell Research;2024

4. Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study;Clinical Lymphoma Myeloma and Leukemia;2023-12

5. Experts’ consensus on the definition and management of high risk multiple myeloma;Frontiers in Oncology;2023-01-23